EFPIA - NEWSLETTER

EFPIA Newsletter 17 April 2025

A Strategy for European Life Sciences

Our submission on the call for evidence on the new Strategy for European Life Sciences can be found here.

EFPIA welcomes the Commission initiative to develop a robust EU Life Sciences Strategy to strengthen Europe competitiveness and close the innovation gap with global peers.

The strategy must address challenges across the full value chain, deepen public-private collaboration, and reinforce the link between a thriving industry, world-class research and manufacturing, and equitable access to medicines.

Learn more here.

Pharma CEOs alert President von der Leyen to risk of exodus to the US

CEOs of the research-based pharmaceutical industry issued a stark warning to President von der Leyen that unless Europe delivers rapid, radical policy change then pharmaceutical research, development and manufacturing is increasingly likely to be directed towards the US.

Read more here.

Cardiovascular health takes centre stage with new MEP Group

A significant step forward in addressing the leading cause of death in Europe is set to take place with the official launch of the MEP Cardiovascular Health Group in the European Parliament.

Chaired by MEP Romana Jerković (S&D, Croatia), this cross-party group is poised to place prevention and tackling of cardiovascular disease (CVD) at the forefront of the EU’s health agenda.

Learn more here.

Events

24 APR 2025

IHI online event on childhood cancer research tools Virtual event

Join to discover the results of the ITCC-P4 public-private partnership.

Learn more →

13 MAY 2025

International conference on protein stability – The gap between industry and administration... Södertälje Science Park, Sweden

The objective of this symposium/conference is to create an arena for discussions on the recent research and industrial...

Learn more →

2024 Pipeline Review: Cardiovascular disease (CVD)

Elevated lipoprotein (a) levels are a risk factor for cardiovascular disease. New therapies can reduce the amount of lipoprotein (a) and reduce its associated risks.

Imagine how many strokes and heart attacks could be prevented.

Discover more in our pipeline review.

What we are reading

Czechia training patients for active role in healthcare decision-making 15 April 2025 (Euractiv)

Interview: How COVID reshaped attitudes to vaccination 14 April 2025 (Vaccines Today)

Join our team!

Join our team! We have 5 job opportunities available:

Director, Public Affairs
Manager, Legal Affairs – Corporate Sustainability & Policy
Junior Manager, Public Affairs
Intern, International Affairs
Intern, Legal Affairs

To apply, please send your CV and cover letter to vacancy@efpia.eu. You can find more details here.

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶